Major adverse events
It is very uncertain whether PUL changes major adverse events compared with TURP (very low certainty).
2 findings from 1 review
Major adverse events · men with benign prostatic hyperplasia
It is very uncertain whether aquablation changes major adverse events compared with transurethral resection of the prostate (very low certainty).
1 finding from 1 review
Minor adverse events
1 finding from 1 review
Adverse events (any) · women with heavy menstrual bleeding
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (any) · heavy menstrual bleeding
It is very uncertain whether antifibrinolytics changes adverse events (any) compared with herbal medicines (very low certainty).
1 finding from 1 review
Adverse events (any) · heavy menstrual bleeding
It is very uncertain whether antifibrinolytics changes adverse events (any) compared with levonorgestrel intrauterine system (very low certainty).
1 finding from 1 review
Adverse events (any) · women with heavy menstrual bleeding
Antifibrinolytics showed no clear difference in adverse events (any) compared with no treatment or placebo (low certainty).
1 finding from 1 review
Adverse events (any) · women with heavy menstrual bleeding
Antifibrinolytics may leads to lower adverse events (any) compared with progestogens (low certainty).
1 finding from 1 review
Major adverse events
It is very uncertain whether whole gland primary cryotherapy changes major adverse events compared with external beam radiotherapy (EBRT) (very low certainty).
1 finding from 1 review
Intervention not reported
Minor adverse events · [People] with [Multiple Sclerosis]
1 finding from 1 review
Major adverse events · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers showed no clear difference in major adverse events compared with standard therapy (low certainty).
1 finding from 1 review
Major adverse events · adult patients presenting with symptoms of ureteral stone disease
Alpha‐blockers probably leads to higher major adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Acute adverse events
It is very uncertain whether extended‐field chemoradiotherapy changes acute adverse events compared with pelvic chemoradiotherapy (very low certainty).
1 finding from 1 review
Acute adverse events
Extended‐field radiotherapy probably leads to lower acute adverse events compared with pelvic chemoradiotherapy (moderate certainty).
1 finding from 1 review
Other adverse events · cancer patients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Other adverse events · cancer patients
Olanzapine showed no clear difference in other adverse events compared with placebo/no treatment (low certainty).
1 finding from 1 review
RR 1.71 [0.99, 2.96]
Studies not reported
Low
Total adverse events · Adults with acute asthma
Combination inhaled therapy probably leads to higher total adverse events compared with SABA alone (moderate certainty).
1 finding from 1 review
Intervention not reported
Other adverse events · infantile‐onset Pompe disease
1 finding from 1 review
Major adverse events
Desmopressin showed no clear difference in major adverse events compared with placebo (low certainty).
2 findings from 1 review
Minor adverse events
Desmopressin showed no clear difference in minor adverse events compared with placebo (low certainty).
1 finding from 1 review